

In October 2007, Pfizer announced it will stop making inhaled insulin. This decision was voluntary and was not based on any safety concern; Pfizer states that their inhaled insulin product (Exubera) has not met its expectations in terms of sales. Starting in October 2007, it will be available for an additional three months, which will give people enough time to change from inhaled insulin to another type of insulin or other diabetes medication.
| (Drug Interactions With Inhaled Insulin Continued: Page 2) | |
| Referring Pages | Articles |